Ferrous succinate
- Generic Name
- Ferrous succinate
- Drug Type
- Small Molecule
- Chemical Formula
- C4H4FeO4
- CAS Number
- 10030-90-7
- Unique Ingredient Identifier
- 818ZYK7N91
- Indication
Used in preventing and treating iron-deficiency anemia.
- Associated Conditions
- Iron Deficiency (ID)
Iron Isomaltoside for the Treatment of Anemia in Peritoneal Dialysis Patients
Phase 4
Not yet recruiting
- Conditions
- Renal AnemiaPeritoneal Dialysis (PD)
- Interventions
- First Posted Date
- 2025-02-17
- Last Posted Date
- 2025-02-17
- Lead Sponsor
- Xie Jingyuan, MD
- Target Recruit Count
- 124
- Registration Number
- NCT06830941
A Study of Shengxuening Tablet in the Treatment of Chemotherapy-related Anemia in Hematologic Tumors
Phase 3
Recruiting
- Conditions
- Cancer-Related AnemiaHematological Malignancy
- Interventions
- Drug: Shengxuening Tablet
- First Posted Date
- 2023-03-27
- Last Posted Date
- 2023-08-25
- Lead Sponsor
- Zhongnan Hospital
- Target Recruit Count
- 168
- Registration Number
- NCT05784870
- Locations
- 🇨🇳
Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China
The Effects of Ferric Derisomaltose on Postoperative Anemia in Spinal Deformity Surgery
Phase 4
Recruiting
- Conditions
- Perioperative AnemiaAdultSurgerySpinal Deformity
- Interventions
- First Posted Date
- 2023-02-06
- Last Posted Date
- 2023-10-02
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 120
- Registration Number
- NCT05714007
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
Efficacy and Safety of Ferrous Iron on the Prevention of Vascular Cognitive Impairment Among Patients With Cerebral Infarction/TIA (FAVORITE)
Phase 2
- Conditions
- Dementia, VascularVascular Cognitive ImpairmentIron-deficiencyCerebral InfarctionTIA
- Interventions
- First Posted Date
- 2019-03-27
- Last Posted Date
- 2020-07-13
- Lead Sponsor
- Beijing Tiantan Hospital
- Target Recruit Count
- 1006
- Registration Number
- NCT03891277
- Locations
- 🇨🇳
Beijing tiantan hospital, Beijing, Beijing, China
the Efficacy and Safety of Vitamin C for Iron Supplementation in Adult IDA Patients
Phase 4
Completed
- Conditions
- Anemia, Iron-Deficiency
- Interventions
- Drug: ferrous succinate and vitamin C
- First Posted Date
- 2015-12-16
- Last Posted Date
- 2019-02-25
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 440
- Registration Number
- NCT02631668
- Locations
- 🇨🇳
Hushan Hospital, Shanghai, Shanghai, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath